Headquarters: Oxford, United Kingdom
Founded: 2010
Website: [brainomix.com](https://www.brainomix.com)
Overview
flowchart TD
companies_brainomix["Brainomix"]
style companies_brainomix fill:#4fc3f7,stroke:#333,color:#000
companies_brainomix_0["Company Details"]
companies_brainomix -->|"includes"| companies_brainomix_0
style companies_brainomix_0 fill:#81c784,stroke:#333,color:#000
companies_brainomix_1["Products and Platforms"]
companies_brainomix -->|"includes"| companies_brainomix_1
style companies_brainomix_1 fill:#ef5350,stroke:#333,color:#000
companies_brainomix_2["e-Stroke Platform"]
companies_brainomix -->|"includes"| companies_brainomix_2
style companies_brainomix_2 fill:#ffd54f,stroke:#333,color:#000
companies_brainomix_3["e-CTP CT Perfusion"]
companies_brainomix -->|"includes"| companies_brainomix_3
style companies_brainomix_3 fill:#ce93d8,stroke:#333,color:#000
companies_brainomix_4["e-MRI"]
companies_brainomix -->|"includes"| companies_brainomix_4
style companies_brainomix_4 fill:#4fc3f7,stroke:#333,color:#000
companies_brainomix_5["Technology"]
companies_brainomix -->|"includes"| companies_brainomix_5
style companies_brainomix_5 fill:#81c784,stroke:#333,color:#000
... Headquarters: Oxford, United Kingdom
Founded: 2010
Website: [brainomix.com](https://www.brainomix.com)
Overview
Mermaid diagram (expand to render)
Brainomix is a medical AI company specializing in imaging software for stroke and neurological conditions. The company's flagship product, e-Stroke, uses artificial intelligence to analyze CT and MRI brain scans and help clinicians make faster, more accurate treatment decisions["@brainomix2024"]. Brainomix technology is deployed in over 500 hospitals worldwide and has analyzed millions of scans.
Company Details | Attribute | Details |Headquarters | Oxford, United Kingdom |Founded | 2010 |Focus | AI-powered medical imaging |Products | e-Stroke platform |Hospitals | 500+ worldwide |Scans Analyzed | Millions |
| Product | Modality | Indication | Status |
The e-Stroke platform provides comprehensive stroke imaging analysis:
Automated ASPECTS Scoring : Quantitative assessment of early ischemic changes using Alberta Stroke Program Early CT ScoreCore-Penumbra Mismatch : Identification of salvageable brain tissue to determine treatment eligibilityLarge Vessel Occlusion (LVO) Detection : Automatic identification of vessel occlusionsVolume Quantification : Precise measurement of infarct core and penumbraTreatment Recommendations : Evidence-based guidance for thrombolysis and thrombectomye-CTP (CT Perfusion) CT Perfusion imaging for advanced stroke assessment:
Cerebral blood flow (CBF) mapping
Cerebral blood volume (CBV) measurement
Mean transit time (MTT) analysis
Automated penumbra identification
e-MRI MRI-based stroke assessment:
Diffusion-weighted imaging (DWI) analysis
Fluid-attenuated inversion recovery (FLAIR) assessment
Apparent diffusion coefficient (ADC) mapping
Technology
AI and Machine Learning Brainomix's AI algorithms are trained on millions of annotated images:
Deep learning models for image segmentation
Transfer learning from large medical imaging datasets
Continuous algorithm improvement through clinical feedback
Clinical Decision Support The platform provides:
Automated ASPECTS Scoring : Quantitative assessment of early ischemic changesCore-Penumbra Mismatch : Identification of salvageable brain tissueVessel Occlusion Detection : Automatic large vessel occlusion identificationVolume Calculations : Precise measurements for treatment planningTime Savings : Rapid analysis (<2 minutes) vs. manual review (15-20 minutes)Clinical Evidence Multiple peer-reviewed studies have validated Brainomix technology:
Key Studies | Study | Finding | Impact |
Clinical Benefits
Time savings : 30+ minute reduction in door-to-treatment timeAccuracy : High correlation with expert radiologist assessmentsConsistency : Standardized analysis across institutionsOutcomes : Improved functional outcomes in treated patientsWorkflow : Streamlined imaging triageRelevance to Neurodegenerative Disease While primarily focused on acute stroke, Brainomix technology has significant potential applications in neurodegeneration:
Vascular Dementia
Cerebral small vessel disease : Quantification of white matter hyperintensitiesVascular burden assessment : Total small vessel disease load scoringStroke recurrence risk : Identification of high-risk vascular patternsTreatment monitoring : Assessment of vascular interventions[@vascular2022]Alzheimer's Disease
Neuroimaging biomarkers : Amyloid and tau imaging analysisBrain volume tracking : Hippocampal atrophy measurementWhite matter changes : Leukoaraiosis assessmentVascular contribution : Mixed pathology identificationParkinson's Disease
Vascular parkinsonism : Differentiation from idiopathic PDWhite matter involvement : Assessment of vascular burdenNeuroimaging biomarkers : DaTscan analysis supportCerebral Small Vessel Disease (CSVD)
White matter hyperintensities : Automated segmentation and gradingLacunes : Detection and countingMicrobleeds : Susceptibility-weighted imaging analysisPerivascular spaces : Assessment of perivascular space enlargementMarket Position
Stroke Imaging AI Market Brainomix is a leading player in the stroke imaging AI space:
Competitors : Viz.ai, RapidAI, Zebra Medical VisionDifferentiation : Specialized stroke focus, European market strengthPartnerships : Major hospital networks, stroke systems of careExpansion Opportunities
Neurodegenerative disease imaging
International market expansion
Integration with EHR systems
Tele-neuroradiology support
Regulatory Status
FDA : Cleared for clinical use in USCE Mark : Approved for European marketUK NHS : Adopted across NHS stroke networksSee Also
[Alzheimer's Disease](/diseases/alzheimers-disease)
[Parkinson's Disease](/diseases/parkinsons-disease)
[Vascular Dementia](/diseases/vascular-dementia)
[AI in Neuroscience](/topics/artificial-intelligence-neuroscience)
[Neuroimaging Biomarkers](/topics/neuroimaging-biomarkers)
[Stroke and Neurodegeneration](/topics/stroke-neurodegeneration-connection)
[AI Neurology Companies](/companies/ai-neurology-companies)
[Medical Imaging Companies](/companies/medical-imaging-neurology)
References
[Brainomix, e-Stroke Platform](https://www.brainomix.com/products)
[AI-Automated CT Perfusion in Stroke, Radiology (2021)](https://doi.org/10.1148/radiol.2021204113)
[Clinical Impact of AI Stroke Imaging, Journal of Neuroradiology (2022)](https://doi.org/10.1016/j.jneuroradi.2022.08.001)
[AI in Stroke Care - 2023 Update, Lancet Neurology (2023)](https://doi.org/10.1016/S1474-4422(23)00100-X)
[Vascular Cognitive Impairment and AI Imaging, Alzheimer's & Dementia (2022)](https://doi.org/10.1002/alz.12654) Show full description